Evaluation method and influencing factors of sarcopenia in dialysis patients and renal transplant patients.

Evaluation method and influencing factors of sarcopenia in dialysis patients and renal transplant patients. - Factors affecting sarcopenia in patients with chronic kidney disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044794

Enrollment

150

Registered

2021-08-01

Start date

2021-07-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance dialysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Chronic maintenance hemodialysis patients and peritoneal dialysis patients, renal transplant patients 2. Age 20 years or older 3. Free written consent has been obtained from the patient after full informed consent for participation in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with difficulty in diagnosing sarcopenia (difficulty in assessing physical capacity due to decreased ADL). 2. Patients for whom an abdominal CT has not been performed. 3. Patients who are judged by the principal investigator or sub-investigator to be inappropriate as research subjects. 4. Patients with insufficient ability to consent due to cognitive decline.

Design outcomes

Primary

Measure	Time frame
To investigate the association of PMI and iliopsoas muscle volume with criteria for sarcopenia and to determine cutoff values for PMI in dialysis patients.	—

Countries

Japan

Contacts

Public ContactHiroki Adachi

Kanazawa Medical University Department of Nephrology

m5240a@kanazawa-med.ac.jp0762862211

Outcome results